AstraZeneca | eNCA

AstraZeneca rapidly developed the successful Covid-19 jab during the coronavirus pandemic which erupted in the first half of 2020

AstraZeneca withdraws COVID-19 vaccine as demand dives

08 May 2024

AstraZeneca's share price was down 2.14 percent at the start of London trading on Monday.

AstraZeneca sees annual profit almost double

08 February 2024

The takeover marks the latest push by AstraZeneca chief executive Pascal Soriot to bolster the Covid vaccine maker's pipeline of new products

AstraZeneca buys US biotech firm CinCor

09 January 2023

Net profit for the Covid-vaccine maker came in at $1.64 billion in the July-September period

AstraZeneca returns to profit on higher drugs revenue

10 November 2022